New Targets For Biologic Rheumatoid Arthritis Therapy Featured At ACR
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Identification of new molecular targets is a central focus of research in novel biologic therapies for rheumatoid arthritis, according to presentations at the American College of Rheumatology annual scientific meeting.